INTRODUCTION

Top Abstract Introduction Materials and Methods Results Discussion References

The vpr gene from human immunodeficiency virus type 1 (HIV-1) encodes a 96-amino-acid protein with multiple functions in the viral life cycle. The first reported role for vpr was a moderate transactivation effect on the viral promoter, the long terminal repeat (LTR) (13). HIV-1 mutants with deletions in vpr replicate with slower kinetics than wild-type viruses do (5, 14). Vpr is encapsidated into virions in significant amounts (1, 12, 57). The presence of vpr in the viral particle facilitates efficient infection of macrophages and other nondividing cells (14, 17, 23) by mediating active nuclear import of preintegration complexes (16, 44). In addition, the presence of vpr enhances the transcriptional activity of the viral LTR in macrophages and T cells, allowing the production of a larger viral progeny (18, 52).

HIV-1 vpr contributes to the multiple cytopathic effects induced by HIV-1 by inducing cell cycle arrest in G₂ (22, 27, 45, 46) and apoptosis (11, 49, 50, 55). The primate immunodeficiency virus strain, SIVagm, encodes an accessory gene, vpr^AGM, which bears sequence (31% amino acid identity) and functional conservation with vpr^HIV-1. At a functional level, vpr^AGM shares with vpr^HIV-1 its abilities to transactivate the viral LTR (39), cause cell cycle arrest in G₂ (42, 51), and become incorporated in the virion particles for subsequent participation in nuclear import of preintegration complexes (1, 8).

Earlier studies have suggested that the HIV-1 and SIVagm vpr genes are functionally conserved in virion encapsidation, nuclear localization, cell cycle arrest, and effect on viral replication kinetics. However, noticeable differences have also been reported. Deletion of SIVagm vpr appears to have a more profound effect on viral replication in primary macrophages and peripheral blood mononuclear cells than does deletion of HIV-1 vpr. SIVagm vpr mutants are incapable of replication in nondividing cells, while HIV-1 vpr mutants are able to replicate at low level. To explain this difference, it was suggested by Campbell and Hirsch that HIV-1 contains redundant nuclear localization signals in addition to Vpr, such as the matrix protein, and perhaps that is not the case for SIVagm (8).

The cause-effect relationships among the different functions of vpr are currently being investigated. The present study focuses on how transactivation, G₂ arrest, and apoptosis are related at a functional level, for both vpr^AGM and vpr^HIV-1.

	MATERIALS AND METHODS

Top Abstract Introduction Materials and Methods Results Discussion References

Cell lines. The human breast cancer cell line SKBR3 was cultured in RPMI 1640 medium (BioWhittaker, Walkersville, Md.) containing 10% fetal calf serum (FCS) (Omega Scientific, Inc., Bedford, Ohio). African green monkey kidney Cos-7 cells were grown in Dulbecco's modified Eagle's medium (DMEM; BioWhittaker) supplemented with 10% FCS. The human embryonic 293T cells were propagated in Iscove's modified Dulbecco's medium (BioWhittaker) plus 10% FCS. The human cervical cancer cell line HeLa was maintained in DMEM with 5% FCS.

Plasmid constructs. Mammalian vectors directing the expression of thy-1 and a vpr gene, vpr^HIV-1, vpr^HIV-1-FS, or vpr^AGM, were described previously (42). A vector expressing thy-1 and vpr^AGM-FS was constructed by digesting the vpr^AGM expression vector with the restriction endonuclease BsrGI, treating it with Klenow to fill the ends, and religating. This treatment generated a frameshift at codon 85. The vector, pCMV-thy was described earlier (41).

(i) Vectors for luciferase expression. LTR^HIV-1-Luc was constructed by subcloning the 5' LTR of HIV-1_NL4-3 (2) into pBluescript II KS(+) (Invitrogen, Carlsbad, Calif.) using AvrII and HindIII. A fragment containing the luciferase gene followed by the simian virus 40 polyadenylation sequences was cloned downstream from the LTR using XhoI and XbaI. LTR^AGM-Luc was constructed by replacing the HIV-1 LTR in the previous construct by that of pSIV_agm677 (26), using HindIII and XbaI.

(ii) Plasmids for production of defective lentivirus vectors. The envelope construct HCMV-VSVG (7) and the packaging construct pCMVR8.2-vpr (4) were described previously. D102 is a defective HIV-1-derived lentivirus vector that is described in detail elsewhere (Y. Zhu and V. Planelles, submitted for publication). Briefly, D102-mHSA was derived from the previously described vector HIV-GFP (49) as follows. A 484-bp PflMI-SalI fragment from HIV-GFP was replaced by a 630-bp fragment from pNL-r-HSAS (25) using the same restriction enzymes. This resulted in replacement of the vpr open reading frame with that of the murine heat-stable antigen (mHSA) and also in the inclusion of a unique restriction site, XbaI, for subsequent cloning of additional genes replacing the gene encoding mHSA. D102-vprH and D102-vprA were constructed by replacing mHSA with vpr^HIV-1 or vpr^AGM, respectively, using the newly introduced XbaI site and a natural site, EcoRI, within the vpr remnant.

(iii) Construction of green fluorescent protein (GFP) fusions. pEGFP-N1 (Clontech, Palo Alto, Calif.) was digested with BglII and BamHI and religated to create pEGFP-bam/bgl-. A ligation was then performed to create pGFP-flex with the following three DNA fragments: an NheI-BsrGI fragment from pEGFP-bam/bgl-, a BamHI-NheI fragment from pcDNA-2, and a flexible linker, which was from pUC-flex (10), digested with BsrGI and BamHI. To construct a GFP-vpr^HIV-1 expression plasmid, an NcoI-XbaI fragment from BSVpr-Thy (42) was subcloned into pGFP-flex digested with XhoI and XbaI. In the previous subcloning, the BsrGI and XhoI sites were filled with Klenow. A GFP-vpr^AGM expression plasmid was made by subcloning the SIVagm vpr cDNA from the vector, BS-677X-Thy (42), using the same restriction sites and recipient plasmid as for its HIV-1 counterpart.

Transfections and luciferase assays. Transient transfection of cells for luciferase measurement was performed using the TransFast reagent (Promega Corp., Madison, Wis.) as recommended by the manufacturer. Cells were plated at a density of 10⁵/well in 12-well plates. One day later, 0.25 µg of LTR^HIV-1-Luc or LTR^AGM-Luc reporter plasmid and 0.25 µg of a vpr expression plasmid were mixed with 1.5 µl of TransFast reagent in 0.2 ml of serum-free RPMI 1640 (SKBR3 cells) or DMEM (Cos-7 cells), and the mixture was incubated at room temperature for 30 min. The mixture was then added to the cells and incubated at 37°C for 1 h, and then 2 ml of RPMI 1640 with 10% FCS was added. The control plasmid was pCMV-thy. After 72 h, the cells were lysed and assayed for luciferase activity with a commercially available luciferase assay kit (Promega Corp.), using a LumiCount microplate reader (Packard Instrument Corp., Meriden, Conn.). The luciferase assay was performed using the following settings: PMT, 1,100 V; gain level, 5.0; and read length, 0.5 s. The background of the luciferase reading was 25 ± 15 light units for six measurements of lysates from uninfected cells. Each experiment was performed in triplicate, and each measurement was the average of duplicate readings. Luciferase light units were normalized to 1 µg of protein content (Bio-Rad Laboratories, Hercules, Calif.) in cell lysates. Light units in experimental wells were converted to fold increase with respect to control wells.

Viral vector production and titer determination. Lentivirus vectors were produced by transient transfection of 293-T cells. D102-mHSA, D102-vprH, or D102-vprA was cotransfected with HCMV-VSVG and pCMV-R8.2vpr using the calcium phosphate-mediated transfection. Virus was collected at 48, 72, 96 h posttransfection. The harvested supernatants were precleared by low-speed centrifugation at 2,000 rpm in a Sorvall RT7 with an RTH-750 rotor (Sorvall) and pelleted by ultracentrifugation at 25,000 rpm in a Discovery 100S centrifuge with a Surespin 630 rotor (Sorvall, Newton, Conn.). Virus pellets were resuspended in fresh tissue culture medium and frozen at 80°C. Vector titers were measured by infection of HeLa cells as described below, followed by flow cytometric analysis of cells positive for the reporter molecule, GFP. Vector titers were calculated as follows: titer = (F × C₀ / V) × D, where F is the frequency of GFP-positive cells by flow cytometry, C₀ is the total number of target cells at the time of infection; V is the volume of inoculum, and D is the virus dilution factor. The virus dilution factor (D) used for titer determinations was 10. The total number of target cells at the time of infection was 10⁶.

Flow cytometry. Cells were harvested and analyzed by direct immunofluorescence for GFP expression and with propidium iodide to analyze the DNA content. The cells were detached with 2 mM EDTA, washed in phosphate-buffered saline (PBS), fixed with 0.2% paraformaldehyde in PBS for 1 h, and stained with propidium iodide solution (20 µg of propidium iodide per ml, 0.2% Triton X-100, and 11.25 Kunitz units of RNase A per ml in PBS). The percentage of GFP-positive cells in G₂/M was assessed and compared to that of untreated control cells. Flow cytometric analysis was performed in an Epics Elite ESP analyzer (Coulter Corp., Hialeah, Fla.). Gates for detection of GFP were established using mock-infected cells as background. Because electronic settings varied from experiment to experiment, gates were defined such that the percentage of false-positive events was not higher than 0.3% in the mock-infected population. Cell cycle analysis was performed using Multicycle AV software (Phoenix Flow Systems, San Diego, Calif.).

TdT-mediated dUTP-biotin nick end labeling (TUNEL). To detect in situ apoptosis, the TdT-FragEL kit (Oncogene Research Products, Cambridge, Mass.) was used as specified by the manufacturer. Cells were seeded at 2 × 10⁴ cells/well in chamber slides (Nalge Nunc International, Rochester, N.Y.). At 48 h following infection, cells were inspected for GFP expression to measure the level of infection. At 72 h postinfection, medium was removed and the cells were fixed with 4% formaldehyde (in PBS) for 10 min, washed with 80% ethanol, and stored overnight at 20°C. After being washed with Tris-buffered saline (TBS), the cells were permeabilized with proteinase K at room temperature for 5 min and washed again with TBS. The cells were then treated with 30% H₂O₂ in methanol for 5 min to inactivate endogenous peroxidases. Following application of equilibration buffer, the cells were incubated with a reaction mixture containing terminal deoxynucleotidyltransferase (TdT)- and biotin-labeled dUTP for 1.5 h in a humidified chamber at 37°C. The reaction was stopped by the supplied stop buffer. After the samples were washed with TBS, streptavidin-horseradish peroxidase conjugate was applied in a humidified chamber for 30 min. The cells were then counterstained with methyl green.

Drugs. Caffeine was purchased from Sigma Chemical Co., and dissolved in water at 50 mM, and kept frozen at 80°C. Taxol (paclitaxel; Sigma Chemical Co.) was dissolved in dimethyl sulfoxide (Fisher Scientific, Fair Lawn, N.J.) at 7 mM and kept frozen at 80°C.

	RESULTS

Top Abstract Introduction Materials and Methods Results Discussion References

Induction of G₂ arrest by vpr^AGM and vpr^HIV-1 differs in human and African green monkey cells. We previously described a transient-transfection assay for the study of cell cycle effects by vpr^HIV-1 and related genes from primate lentiviruses (42). This method is based on the use of dual expression vectors which direct the expression of vpr and a reporter gene, murine thy-1 (Fig. 1A). Transfected cells are analyzed by direct immunofluorescence for Thy-1 surface expression and with propidium iodide for DNA content (see Materials and Methods) using flow cytometry. For simplicity, only the cell cycle profiles of Thy-1-positive cells (transfected) cells are shown (Fig. 2).

View larger version (33K): [in this window] [in a new window]   FIG. 1.   Expression vectors used for analysis of cell cycle distribution and transactivation. (A) Dual expression vectors for vpr variants and the reporter gene, thy-1. Arrows denote promoters. SV40 p(A), simian virus 40 polyadenylation signal; CMV IE, human cytomegalovirus immediate-early promoter; vprHIV-1-FS and vprAGM-FS, carboxy-terminal truncations of vprHIV-1 and vprAGM, generated by introducing frameshift mutations at codons 64 and 85, respectively. (B) Luciferase reporter vectors in which the viral LTR serve as a basal promoters.

View larger version (40K): [in this window] [in a new window]   FIG. 2.   Flow cytometric analysis of vpr-induced G2 arrest. Cells were transfected with control plasmid (pCMV-thy) or dual expression vectors encoding the murine thy-1 gene and the indicated vpr version (top of each histogram). At 48 h after transfection, the cells were analyzed for thy-1 expression and DNA content. Where indicated, the cells were treated by adding 2 mM caffeine to the medium 1 h posttransfection. Transfected cells were distinguished from untransfected ones by Thy-1 expression and were electronically gated. Histograms depict the cell cycle profile of gated Thy-1-positive cells only. The left peaks constitute cells in G1, and the right peaks constitute cells in G2/M; cells in S phase are between the G1 and G2 peaks. The frequencies of cells in different stages of the cell cycle were calculated using Multicycle AV software (Phoenix Flow Systems, San Diego, Calif.).

Relationship between transactivation and G₂ arrest. The ability of vpr^HIV-1 to induce G₂ arrest has been linked to another property of vpr, transactivation of the viral promoter, the LTR. It was shown that the transcriptional activity of the LTR was increased by 5- to 10-fold (18, 20) during the G₂ phase compared to that during the G₁ phase. Consequently, infected cells that express vpr^HIV-1 are capable of producing 5- to 10-fold-larger amounts of viral progeny than are cells infected with vpr-deleted viruses (18, 20). A direct result of this enhanced transcriptional activity is that HIV-1 strains expressing functional vpr alleles are capable of spreading in culture with faster kinetics than are isogenic strains with mutations in vpr (13, 27, 37).

View larger version (24K): [in this window] [in a new window]   FIG. 3.   Transactivation of vprHIV-1 and vprAGM on the viral LTR. Cos-7 (A) and SKBR3 (B) cells were transiently transfected with a luciferase reporter construct (LTRAGM-Luc or LTRHIV-1-Luc) and a vpr expression construct. The structures of all constructs, except the control plasmid, are shown in Fig. 1. The control plasmid was pCMV-thy. At 48 h posttransfection, the cells were lysed in 100 µl of lysis buffer and a 20-µl volume was used to measure luciferase activity. Experiments were normalized to light units measured with control plasmid, to which an arbitrary value of 1 was assigned. All experiments were performed in triplicate, and standard deviations are shown as error bars.

Effect of caffeine on transactivation by vpr^HIV-1 and vpr^AGM. Caffeine, a methylxanthine, inhibits DNA damage-induced (36) and vpr^HIV-1-induced (43) cell cycle arrest. To further examine whether transactivation by vpr^AGM is independent of cell cycle blockade, we performed an experiment in which caffeine was used to relieve G₂ arrest and the cells were analyzed for transactivation (Fig. 4). Incubation with 2 mM caffeine inhibited vpr^HIV-1-induced G₂ arrest as well as vpr^AGM-induced G₂ arrest (Fig. 2, bottom panels). Treatment with caffeine led to nearly complete (94%) inhibition of vpr^HIV-1 transactivation effect (Fig. 4A). In contrast, treatment with caffeine had no significant effect on the transactivation by vpr^AGM in human cells (Fig. 4B) or in African green monkey kidney cells (Fig. 4C). Thus, it appears that vpr^AGM can induce transactivation of the viral LTR by a mechanism which is independent of the induction of cell cycle arrest, and it represents an important mechanistic difference from the proposed mode of action of vpr^HIV-1 (18).

View larger version (22K): [in this window] [in a new window]   FIG. 4.   Effect of caffeine on transactivation. SKBR3 (A and B) or Cos-7 (C) cells were transiently transfected with vprHIV-1 (A) or vprAGM (B and C) vectors and 2 mM caffeine was added to the medium 1 h later; at 72 h posttransfection, the cells were lysed and analyzed for luciferase activity as described in the legend to Fig. 3.

Effect of taxol on transactivation of the HIV-1 and SIVagm LTRs. It has been suggested that the transactivation effect induced by vpr^HIV-1 is a result of a higher transcriptional level of the viral LTR in the G₂ phase of the cell cycle (18). According to this hypothesis, one would expect that drug-induced G₂ arrest would produce similar transactivation of the LTR. To test this idea, cells were treated with a chemotherapeutic agent, taxol, which specifically induces cell cycle arrest at the G₂/M transition by inhibiting the formation of the mitotic spindle (19, 24, 31). Treatment of SKBR3 cells with taxol induced G₂ arrest (Fig. 5A) and transactivation of the HIV-1 LTR (Fig. 5B) in human cells. Similarly, taxol induced G₂ arrest in Cos-7 cells (data not shown) and increased activity of the SIVagm LTR (Fig. 5B).

View larger version (43K): [in this window] [in a new window]   FIG. 5.   Induction of G2/M arrest by taxol leads to LTR transactivation. (A) SKBR3 cells were incubated in medium containing 90 nM taxol [(+) taxol] or medium alone [() taxol] and were assayed for cell cycle profile after 48 h. (B) Cells were transfected with the indicated reporter constructs; at 1 h posttransfection they were incubated in medium containing taxol or medium alone, and at 72 h they were lysed and analyzed for luciferase activity. (C) SKBR3 cells were transfected with the indicated plasmids and treated with 90 nM taxol or medium alone; at 72 h posttransfection they were lysed and analyzed for luciferase activity.

Induction of apoptosis by vpr and its relationship to cell cycle perturbation. Cells that are induced to arrest in G₂ by either vpr^HIV-1 expression or infection with HIV-1 appear to be unable to enter the cell cycle again and, instead, undergo apoptosis (6, 49, 50). Because of the structural and functional similarities between vpr^HIV-1 and vpr^AGM, we wished to investigate the role of vpr^AGM in induction of apoptosis. In particular, we designed experiments to determine (i) whether expression of vpr^AGM leads to apoptosis; (ii) whether apoptosis by vpr^AGM is subject to species specificity, as is G₂ arrest induction; and (iii) whether induction of apoptosis, for both vpr^HIV-1 and vpr^AGM, is linked to the induction of G₂ arrest.

View larger version (32K): [in this window] [in a new window]   FIG. 6.   Viral vectors used for transduction of vprAGM, vprHIV-1, and mHSA. (A) Lentivirus transfer vectors were constructed by incorporating the indicated genes into the defective vector, D102; the vpr open reading frame was eliminated by mutating the translational start codon, which overlaps with vif; an XbaI restriction endonuclease site was introduced for convenient cloning of desired genes into this region of the genome; an EcoRI site was a present and was used as the downstream cloning site; discontinuous lines depict splicing donors (SD) and acceptors (SA). (B) The lentivirus packaging construct, pCMVR8.2-vpr, was described previously (4).

View larger version (112K): [in this window] [in a new window]   FIG. 7.   Induction of apoptosis by and subcellular localization of vprHIV-1 and vprAGM. (A) Apoptosis induction in Cos-7 cells. The cells were either mock infected or infected with one of the indicated lentivirus vectors and assayed for apoptosis at 72 h postinfection, using the TUNEL method; levels of infection were quantitated by measuring the frequency of GFP-positive cells and were between 80 and 95% for all experiments. (B) Apoptosis induction in HeLa cells. Experiments were performed in parallel with those in panel A. (C) Subcellular localization of GFP-vpr fusion proteins. Expression vectors bearing indicated fusion proteins were transiently transfected into HeLa or Cos-7 cells and visualized using fluorescence microscopy after 24 h.

View larger version (19K): [in this window] [in a new window]   FIG. 8.   Effect of caffeine on the induction of apoptosis by vprHIV-1 and vprAGM. Infections and apoptosis measurements were performed as described in the legend to Fig. 7; TUNEL-positive (apoptotic) cells were visually counted, and the levels of apoptosis were expressed as a percentage of the total cells counted; the percentage of apoptotic cells in mock infections was always lower than 5%. All experiments were done in triplicate, and standard deviations are shown. (A) SKBR3 cells. (B) Cos-7 cells. (C) Sup-T1 cells.

Nuclear localization of vpr^HIV-1 and vpr^AGM in human versus African green monkey cells. In view of the above results and since vpr^HIV-1 and vpr^AGM naturally localize to the cell nucleus (8, 15, 33, 51, 53), we hypothesized that species-specific differences in the functions of these proteins may be a consequence of potential differences in subcellular localization.

	DISCUSSION

Top Abstract Introduction Materials and Methods Results Discussion References

All known primate lentiviruses contain one or two genes (vpr and/or vpx) that are considered vpr homologs. The various genes in the vpr family are structurally related because they have predicted amino acid sequence homology and encode products that are virion-encapsidated (54). These genes are involved in multiple aspects of the biology of primate lentiviruses, although their precise roles in viral replication and modulation of host functions are still unclear.

We and others previously reported that species-specific factors modulate the induction of G₂ arrest by members of the vpr family (42, 51). SIVagm and SIVsyk vpr genes are capable of arresting African green monkey kidney cells but are unable to do so in human cells. In contrast, HIV-1, HIV-2, and SIVsm vpr genes function in both simian and human cell types, although SIVsm Vpr functions more efficiently in simian cells than it does in human cells. These differences could not be explained on the basis of differential protein stability or subcellular localization (51). The species-specific cell cycle arrest differences between SIVagm and HIV-1 Vpr proteins indicate that these proteins may signal through cellular pathways that are divergent among primates.

We first compared vpr^AGM and vpr^HIV-1 at the level of transactivation. We wished to ascertain whether transactivation by vpr^AGM is species specific, as is its ability to induce G₂ arrest. Surprisingly, vpr^AGM was able to induce transactivation in human cells, despite its inability to induce cell cycle alteration in these cells. This observation suggests that vpr^AGM may exert transactivation by a mechanism that is, at least in part, independent of cell cycle manipulation. To corroborate this observation, we resorted to the use of caffeine, a known inhibitor of vpr-induced (43) and DNA damage-induced (36) G₂ arrest. Caffeine potently inhibited the cell cycle arrest by vpr^AGM in African green monkey kidney cells but produced little or no inhibition of its transactivation effect in either monkey or human cells.

The transactivation effects reported here and elsewhere for the various primate vpr genes are modest compared with the transactivation effects exerted by other, more classical viral transactivators (e.g., HIV-1 tat or human T-cell leukemia virus tax). The importance of vpr-induced transactivation, however, is underscored by two observations. First, HIV-1, HIV-2, SIVmac, and SIVagm vpr genes are able to transactivate their respective LTRs (39). This observation establishes the conservation of this function through evolution. Second, experiments in which the abilities of tat and vpr to transactivate were tested in parallel indicated that they were not mutually exclusive but were synergistic (28, 47). Thus, coexpression of the two genes provided a multiplicative effect on the promoter activity of the LTR.

We also wished to examine whether the ability of vpr^HIV-1 to cause apoptosis would be paralleled by vpr^AGM. Indeed, vpr^AGM is capable of inducing apoptosis in African green monkey kidney cells. This induction of apoptosis was not observed when vpr^AGM was expressed in human cells, and therefore apoptosis appears be determined by species-specific factors.

Abrogation of the cell cycle effect by caffeine treatment suppressed the levels of apoptosis by vpr^AGM, as it did for vpr^HIV-1. The potential link between the induction of G₂ arrest and the onset of apoptosis is likely to be complex, since multiple signaling connections have been proposed. Perhaps the area of radiation-induced DNA damage has produced the clearest results to date. DNA damage is a natural signal that may induce cell cycle arrest and apoptosis. Cell cycle arrest following cellular insult allows for the repair of damaged DNA to protect the organism from the repercussions of mutation (21). Cell cycle block can occur before DNA replication, at the G₁/S checkpoint, or before chromosome segregation, at the G₂/M checkpoint (21, 38). Many DNA-damaging agents, including certain antineoplastic drugs, exert their effect at the G₂/M phase (9) and, ultimately, commit the cell to death (32). The effects of vpr, specifically the G₂ block, may be mediated along similar pathways to the effects of genotoxic agents (43).

It was initially thought that the cell cycle perturbation function of vpr^HIV-1 would require that the protein be localized in the nucleus. This was supported by experiments by Di Marzio et al. (15), who failed to find vpr^HIV-1 mutants that could cause G₂ arrest in the absence of nuclear localization. Later mutagenesis experiments demonstrated that nuclear localization was not a requisite for vpr^HIV-1 to function as a cell cycle inhibitor (33, 53). We tested whether the subcellular localization of vpr^AGM might explain the species specificity of the effects of this protein. We found that in both human and African green monkey kidney cells a GFP-vpr^AGM fusion protein is also found in the nucleus. Thus, subcellular localization does not explain the inability of vpr^AGM to cause G₂ arrest and apoptosis in human cells.

Our results point out important functional differences between the HIV-1 and SIVagm vpr genes (Fig. 9). HIV-1 vpr appears to induce G₂ arrest as a primary effect, whereas transactivation and apoptosis appear to be downstream effects of G₂ arrest. Thus, inhibition of G₂ arrest will abrogate such downstream effects. SIVagm vpr induces these three effects independently. Thus, abrogation of vpr^AGM-induced G₂ arrest has no effect on the onset of apoptosis or transactivation of the LTR.

View larger version (16K): [in this window] [in a new window]   FIG. 9.   Proposed model to summarize the relationships among various functions of vprHIV-1 and vprAGM. The observed effects of drugs are depicted in grey. Caffeine inhibits vprHIV-1 G2 arrest and also its downstream effects, apoptosis and transactivation. For vprAGM, caffeine inhibits G2 arrest but not apoptosis or transactivation. Transactivation by vprAGM is due, in part, to a cell cycle-independent mechanism, and therefore, caffeine has little or no effect on transactivation. However, the SIVagm LTR is also responsive to cell cycle arrest since taxol can induce transactivation. Because treatment with caffeine does not significantly affect transactivation, the significance of G2 arrest for vprAGM is uncertain (question mark).

Taken together, our results suggest that while the multiple functions of vpr are conserved among various primate lentiviruses, the mechanisms leading to the execution of such functions are divergent.